Works matching DE "IRINOTECAN"


Results: 1804
    1
    2
    3
    4
    5
    6
    7
    8

    Postmortem study of organ-specific toxicity in glioblastoma patients treated with a combination of temozolomide, irinotecan and bevacizumab.

    Published in:
    Journal of Neuro-Oncology, 2022, v. 160, n. 1, p. 221, doi. 10.1007/s11060-022-04144-y
    By:
    • Lu, Guangrong;
    • Zhu, Ping;
    • Rao, Mayank;
    • Linendoll, Nadine;
    • Buja, L. Maximilian;
    • Bhattacharjee, Meenakshi B.;
    • Brown, Robert E.;
    • Ballester, Leomar Y.;
    • Tian, Xuejun;
    • Pilichowska, Monika;
    • Wu, Julian K.;
    • Hergenroeder, Georgene W.;
    • Glass, Williams F.;
    • Chen, Lei;
    • Zhang, Rongzhen;
    • Pillai, Anil K.;
    • Hunter, Robert L.;
    • Zhu, Jay-Jiguang
    Publication type:
    Article
    9

    The role of irinotecan-bevacizumab as rescue regimen in children with low-grade gliomas: a retrospective nationwide study in 72 patients.

    Published in:
    Journal of Neuro-Oncology, 2022, v. 157, n. 2, p. 355, doi. 10.1007/s11060-022-03970-4
    By:
    • de Marcellus, Charles;
    • Tauziède-Espariat, Arnault;
    • Cuinet, Aurélie;
    • Pasqualini, Claudia;
    • Robert, Matthieu P.;
    • Beccaria, Kevin;
    • Puget, Stéphanie;
    • Boddaert, Nathalie;
    • Figarella-Branger, Dominique;
    • De Carli, Emilie;
    • Bourdeaut, Franck;
    • Leblond, Pierre;
    • Fouyssac, Fanny;
    • Andre, Nicolas;
    • Bertozzi, Anne I.;
    • Butel, Thibaut;
    • Dufour, Christelle;
    • Valteau-Couanet, Dominique;
    • Varlet, Pascale;
    • Grill, Jacques
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    A phase II single-arm study of irinotecan in combination with temozolomide (TEMIRI) in children with newly diagnosed high grade glioma: a joint ITCC and SIOPE-brain tumour study.

    Published in:
    Journal of Neuro-Oncology, 2013, v. 113, n. 1, p. 127, doi. 10.1007/s11060-013-1098-2
    By:
    • Hargrave, Darren;
    • Geoerger, Birgit;
    • Frappaz, Didier;
    • Pietsch, Torsten;
    • Gesner, Lyle;
    • Cisar, Laura;
    • Breazna, Aurora;
    • Dorman, Andrew;
    • Cruz-Martinez, Ofelia;
    • Fuster, Jose;
    • Rialland, Xavier;
    • Icher, Céline;
    • Leblond, Pierre;
    • Ashley, David;
    • Perilongo, Giorgio;
    • Elliott, Martin;
    • English, Martin;
    • Clausen, Niels;
    • Grill, Jacques
    Publication type:
    Article
    21

    In Vivo Topoisomerase I Inhibition Attenuates the Expression of Hypoxia-Inducible Factor 1α Target Genes and Decreases Tumor Angiogenesis.

    Published in:
    Molecular Medicine, 2012, v. 18, n. 1, p. 83, doi. 10.2119/molmed.2011.00120
    By:
    • Guérin, Eric;
    • Raffelsberger, Wolfgang;
    • Pencreach, Erwan;
    • Maier, Armin;
    • Neuville, Agnès;
    • Schneider, Anne;
    • Bachellier, Philippe;
    • Rohr, Serge;
    • Petitprez, Amélie;
    • Poch, Olivier;
    • Moras, Dino;
    • Oudet, Pierre;
    • Larsen, Annette K.;
    • Gaub, Marie-Pierre;
    • Guenot, Dominique
    Publication type:
    Article
    22
    23
    24
    25

    Sequential therapy of refractory metastatic pancreatic cancer with 5-FU/LV/irinotecan (FOLFIRI) vs. 5-FU/LV/oxaliplatin (OFF). The PANTHEON trial (AIO PAK 0116).

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 7, p. 1, doi. 10.1007/s00432-024-05827-x
    By:
    • Modest, Dominik Paul;
    • Heinemann, Volker;
    • Schütt, Philipp;
    • Angermeier, Stefan;
    • Haberkorn, Mike;
    • Waidmann, Oliver;
    • Graeven, Ullrich;
    • Wille, Kai;
    • Kunzmann, Volker;
    • Henze, Larissa;
    • Constantin, Christian;
    • de Wit, Maike;
    • Denzlinger, Claudio;
    • Ballhausen, Alexej;
    • Kurreck, Annika;
    • Jelas, Ivan;
    • Alig, Annabel Helga Sophie;
    • Stahler, Arndt;
    • Stintzing, Sebastian;
    • Oettle, Helmut
    Publication type:
    Article
    26
    27

    Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 8, p. 1581, doi. 10.1007/s00432-018-2671-z
    By:
    • Schaub, Christina;
    • Kebir, Sied;
    • Junold, Nina;
    • Hattingen, Elke;
    • Schäfer, Niklas;
    • Steinbach, Joachim P.;
    • Weyerbrock, Astrid;
    • Hau, Peter;
    • Goldbrunner, Roland;
    • Niessen, Michael;
    • Mack, Frederic;
    • Stuplich, Moritz;
    • Tzaridis, Theophilos;
    • Bähr, Oliver;
    • Kortmann, Rolf-Dieter;
    • Schlegel, Uwe;
    • Schmidt-Graf, Friederike;
    • Rohde, Veit;
    • Braun, Christian;
    • Hänel, Mathias
    Publication type:
    Article
    28
    29

    Lipid-Based Nanoparticle Formulation of Diallyl Trisulfide Chemosensitizes the Growth Inhibitory Activity of Doxorubicin in Colorectal Cancer Model: A Novel In Vitro, In Vivo and In Silico Analysis.

    Published in:
    Molecules, 2022, v. 27, n. 7, p. 2192, doi. 10.3390/molecules27072192
    By:
    • Alrumaihi, Faris;
    • Khan, Masood Alam;
    • Babiker, Ali Yousif;
    • Alsaweed, Mohammed;
    • Azam, Faizul;
    • Allemailem, Khaled S.;
    • Almatroudi, Ahmad A.;
    • Ahamad, Syed Rizwan;
    • Alsugoor, Mahdi H.;
    • Alharbi, Khloud Nawaf;
    • Almansour, Nahlah Makki;
    • Khan, Arif
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50